McKesson Corporation $MCK Shares Purchased by Focus Partners Advisor Solutions LLC

Focus Partners Advisor Solutions LLC increased its position in shares of McKesson Corporation (NYSE:MCK) by 31.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,598 shares of the company’s stock after purchasing an additional 620 shares during the quarter. Focus Partners Advisor Solutions LLC’s holdings in McKesson were worth $2,200,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its stake in shares of McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after buying an additional 798 shares in the last quarter. Caxton Associates LLP purchased a new stake in McKesson during the 1st quarter valued at about $233,000. Sivia Capital Partners LLC raised its holdings in McKesson by 77.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after acquiring an additional 300 shares during the last quarter. Versor Investments LP lifted its stake in McKesson by 26.6% in the 2nd quarter. Versor Investments LP now owns 590 shares of the company’s stock worth $432,000 after purchasing an additional 124 shares in the last quarter. Finally, Bryce Point Capital LLC acquired a new position in shares of McKesson during the 2nd quarter worth approximately $679,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. UBS Group increased their price target on McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Wells Fargo & Company lifted their target price on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. Zacks Research cut shares of McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Finally, Robert W. Baird set a $968.00 price target on shares of McKesson in a research report on Wednesday, January 14th. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $943.50.

Insiders Place Their Bets

In related news, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Maria Martinez sold 349 shares of McKesson stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares of the company’s stock, valued at approximately $282,900.87. This represents a 53.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 3,868 shares of company stock valued at $3,743,820. Insiders own 0.08% of the company’s stock.

McKesson Price Performance

Shares of MCK opened at $977.51 on Thursday. The firm has a 50-day simple moving average of $878.63 and a two-hundred day simple moving average of $813.21. The stock has a market cap of $119.74 billion, a PE ratio of 28.11, a P/E/G ratio of 1.60 and a beta of 0.38. McKesson Corporation has a 1-year low of $621.88 and a 1-year high of $999.00.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same period in the prior year, the business posted $8.03 EPS. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. McKesson’s payout ratio is presently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.